Product Description
DESCRIPTION:
Montor-LC syrup is a combination of Montelukast Sodium and Levocetirizine. Montelukast Sodium is a selective and orally active leukotriene receptor antagonist that inhibits the cysteine leukotriene (CysLT1) receptor. Levocetirizine is a third-generation non-sedative antihistamine developed from the second-generation antihistamine Cetirizine. Chemically, Levocetirizine is the active enantiomer of Cetirizine.
PACKING:
192 x 60 ml
Each 5 ml contains:
|
Montelukast Sodium
|
I.P.
|
|
|
Equivalent to Montelukast
|
I.P.
|
4 mg
|
|
Levocetirizine Dihydrochloride
|
I.P.
|
2.5 mg
|
MECHANISM OF ACTION:
Montelukast inhibits bronchoconstriction due to antigen challenge. Montelukast is a selective leukotriene receptor antagonist of the cysteinyl leukotriene CysLT1 receptor. The cysteinyl leukotrienes (LTC 4, LTD 4, and LTE 4) are arachidonic acid metabolism products released from various cells, including mast cells and eosinophils. Levocetirizine works by blocking histamine receptors. It does not prevent the actual release of histamine from mast cells but prevents binding it to its receptors. This prevents the release of other allergy chemicals and increases blood supply to the area, providing relief.
INDICATIONS:
Relief of symptoms of allergic rhinitis (seasonal or perennial) as prophylaxis in seasonal allergic rhinitis.
CONTRAINDICATIONS:
Contraindicated in patients with known hypersensitivity to Montelukast sodium, Levocetirizine, cetirizine, or any other product component.
SIDE EFFECTS:
Fatigue, dry mouth, dyspepsia, abdominal pain, dizziness, headache, cough, nasal congestion.
DOSAGE:
As directed by the physician.
STORAGE:
Store in a cool & dry place. Protect from light.
PRESENTATION:
60 ml bottle
SHAKE WELL BEFORE USE
BARCODE:
0118906044107530
0108906044107533
Leave a Reply